Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Value-Based Care Leads to Improved Outcomes

In this episode of Highway to Health, host David Kemp speaks with Carrum Health's Chief Commercial Officer Brooke West and Chief Network Officer Christoph Dankert about value-based care and its impact on patient outcomes. Carrum Health connects employers directly with high-quality providers through prospective bundled payments, aiming to reduce costs and improve the patient experience. The conversation highlights how aligning financial incentives with patient results can meaningfully improve healthcare quality and access.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Highway to Health on MarketScale.

By David Kemp · Brooke WestCarrum HealthChristoph DankertDavid Kemp
Share

Key takeaways

01

Value-based care aligns financial incentives with patient outcomes, driving measurable quality improvements over traditional fee-for-service models.

02

Carrum Health negotiates upfront prospective bundles with top-tier providers, creating direct connections between employers and high-quality care.

03

Choosing the right physician is critical — inadequate expertise can have serious consequences, underscoring the need for guided healthcare navigation.

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

In this episode of Highway to Health hosted by David Kemp, Kemp turns the spotlight onto the promising avenue of value-based care with insights from Brook West, the Chief Commercial Officer at Carrum Health, and Christoph Dankert, the Chief Network Officer at Carrum Health.

Brook West shares a personal narrative underscoring the importance of choosing the right physician, revealing how a lack of physician expertise could have jeopardized her father's last days battling cancer. She emphasizes how Carrum Health strives to revolutionize healthcare by forging a direct link between providers and employers, negotiating upfront prospective bundles with the crème de la crème of providers to ensure quality care at optimized costs. Through a meticulous process, Carrum Health aims to enhance patient experience by easing the healthcare navigation and significantly reducing the financial burden, making quality healthcare a more accessible and less daunting prospect for all.

Carrum Health strives to revolutionize healthcare by forging a direct link between providers and employers, negotiating upfront prospective bundles with the crème de la crème of providers to ensure quality care at optimized costs.

Highway to Health

Part of this channel

Highway to Health

Healthcare innovation conversations for executives and technology buyers.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

David Kemp
David KempHealthcare Lead

With experience in coaching college basketball, supporting large healthcare systems through ICD-10, to now leading the healthcare vertical at MarketScale, David enjoys the journey. Craving knowledge is one of David's core values, and he has the opportunity to learn from some of the best as host of the Highway to Health podcast series.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Direct-to-consumer telehealth raises spending, even as ASC investment surges

Direct-to-consumer telehealth raises spending, even as ASC investment surges

A Health Affairs analysis of commercial claims data (2011–13) found 12% of direct-to-consumer telehealth visits replaced visits to other providers and 88% represented new utilization, with net annual spending on acute respiratory illness increasing $45 per telehealth user. Separately, MobiHealthNews reported on August 31, 2026, via a HIMSSCast episode, that Erik Tellefson of Capital One said ambulatory surgery centers “represent one of the clearest growth structures in American healthcare.”

  • 01The most actionable benchmark for finance teams evaluating DTC telehealth is substitution rate, not visit growth. Health Affairs measured 12% substitution and 88% new utilization in commercial claims for acute respiratory illness.
  • 02The $45 per-user net annual spend increase in the Health Affairs analysis is small enough to hide in PMPM reporting but large enough to matter at scale, and it should be stress-tested against virtual-visit eligibility rules and repeat-use patterns.

Sep 2, 2026

HFMA’s new chair is a hospital CFO as Medicare reporting gets more detailed and revenue cycle work gets more technical

HFMA’s new chair is a hospital CFO as Medicare reporting gets more detailed and revenue cycle work gets more technical

HFMA named Corewell Health CFO Matthew E. Cox as its national chair effective June 1, 2026, while elevating revenue cycle and reimbursement leaders to its board, according to HFMA’s GlobeNewswire announcement. The association’s own coverage of CMS’s FY 2027 IPPS/LTCH PPS final rule summary and new Medicare cost-reporting requirements such as Worksheet S-12 indicates a compliance workload that is increasingly data- and documentation-heavy for hospital finance and reporting teams. In parallel, HFMA’s certification catalog, including the Certified Hospital Cost Report Specialist (CHCRS) and Certified Specialist Payment & Reimbursement (CSPR), points to how health systems are professionalizing the skill sets needed to operationalize reimbursement policy changes. For operators, the practical consequence shows up in staffing models, audit readiness, and the data plumbing needed to produce defensible cost reports and faster revenue cycle decisions.

  • 01HFMA’s board slate now visibly includes roles that control the work: a system CFO (Corewell Health) and a chief revenue officer overseeing $7 billion in patient revenue at Orlando Health, per GlobeNewswire. That’s a signal that cost reporting and revenue cycle execution are board-level concerns, not back-office chores.
  • 02Medicare cost reporting is moving toward more granular worksheets and documentation, and each new CMS reporting requirement becomes a data-integration project before it becomes a policy memo, per HFMA’s reporting on Worksheet S-12 and its FY 2027 IPPS/LTCH PPS coverage.
  • 03HFMA’s CHCRS, CRCR, and CSPR credentials provide a concrete way to benchmark internal capability: if cost report preparation, managed care contract terms, and prior auth workflows live in different teams, credentialing can reveal where handoffs are breaking down.

Sep 2, 2026

FDA QMSR ties supplier contracts to inspection prep

FDA QMSR ties supplier contracts to inspection prep

FDA’s Quality Management System Regulation (QMSR) took effect Feb. 2, 2026, incorporating ISO 13485:2016 into 21 CFR Part 820 and shifting inspections to a process-based model under Compliance Program 7382.850, according to MD+DI. That change is starting to show up outside the quality department: medical device OEMs are being pushed to spell out documentation, audit support, and change-control responsibilities in contract manufacturing agreements, as Medical Design and Outsourcing described. Two recent partnership moves, Ratio Therapeutics expanding radiopharmaceutical manufacturing with PharmaLogic in Idaho Falls and Menicon shifting U.S. Rose K manufacturing access to three partners after concluding a prior arrangement, illustrate how multi-party supply chains now need contract terms that map directly to integrated QMS evidence. The operational consequence is simple: under CP 7382.850, a complaint, supplier nonconformance, or process change can pull investigators across CAPA, risk management, purchasing, and design records in one thread, so contracts and quality records have to be built to travel together.

  • 01Under FDA CP 7382.850, inspection risk increasingly sits in the “handoffs” between complaint handling, CAPA, supplier controls, and the Risk Management File, so quality evidence has to be assembled end-to-end, not by department.
  • 02For OEMs outsourcing manufacturing, the most useful contract test in 2026 is whether each clause produces inspectable artifacts, who owns them, where they live, and how fast they can be produced during an audit.
  • 03Multi-partner manufacturing models, like Menicon’s three-partner Rose K availability and Ratio’s capacity expansion with PharmaLogic, raise the bar on configuration control, supplier risk classification, and change notification across sites.

Sep 2, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Experts

David Kemp
David Kemp

Host, Highway to Health

David Kemp is the host of Highway to Health, a MarketScale show and live event series focused on the future of healthcare. He interviews industry innovators and thought leaders exploring value-based care, healthcare navigation, and emerging models in the industry. Kemp brings a conversational, forward-thinking approach to complex healthcare topics.

BW
Brooke West

Chief Commercial Officer

Carrum Health

Brooke West serves as Chief Commercial Officer at Carrum Health, where she leads commercial strategy connecting employers directly with high-quality healthcare providers. She is a vocal advocate for value-based care and has shared personal experience navigating the healthcare system to illustrate the importance of physician expertise and quality networks.

CD
Christoph Dankert

Chief Network Officer

Carrum Health

Christoph Dankert is the Chief Network Officer at Carrum Health, overseeing the company's provider network strategy. He focuses on negotiating prospective bundled payment arrangements with top-tier providers to ensure quality care at optimized costs for employers and patients.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512